In Western Europe, the median value of enterprise value to earnings before interest, tax, depreciation and amortization (EV/EBITDA) in the health & pharmaceuticals sector as of 2025, was a multiple of approximately 15.2x. Heathcare product companies saw the highest EV/EBITDA multiple of nearly 19x in 2025.
Advertisement
Advertisement
Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2025, by industry
Western Europe. Values are as of January each year. A total of 679 companies were included in the calculation for 2025. Figures for years 2019 to 2024 were previously published by the source. Figure for Drugs (Biotechnology) was not given in 2022, 2024, and 2025.
Enterprise value = Market value of equity + Market value of debt - Cash. EBITDA = Estimated by adding depreciation and amortization back to operating income (EBIT). Only positive EBITDA companies.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Leonard N. Stern School of Business. (January 9, 2025). Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2025, by industry [Graph]. In Statista. Retrieved June 24, 2025, from https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business. "Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2025, by industry." Chart. January 9, 2025. Statista. Accessed June 24, 2025. https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business. (2025). Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2025, by industry. Statista. Statista Inc.. Accessed: June 24, 2025. https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business. "Average Ev/Ebitda Multiples in The Health & Pharmaceuticals Sector in Western Europe from 2019 to 2025, by Industry." Statista, Statista Inc., 9 Jan 2025, https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business, Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2025, by industry Statista, https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/ (last visited June 24, 2025)
Average EV/EBITDA multiples in the health & pharmaceuticals sector in Western Europe from 2019 to 2025, by industry [Graph], Leonard N. Stern School of Business, January 9, 2025. [Online]. Available: https://www.statista.com/statistics/1028021/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-europe/
